<img src="https://trc.taboola.com/1321591/log/3/unip?en=page_view" width="0" height="0" style="display:none">
Fact Check Library

Fact Check with Logically.

Download the Free App Today

false
false

CLAIM ID

ae5e5243

Radhika Raje Gaikwad has been declared as the most beautiful woman of the Indian kingdom dynasty by Forbes magazine.

The Forbes magazine has not declared Radhika Raje Gaikwad as the most beautiful woman of the Indian kingdom dynasty. It is a piece of fake news.

The Forbes magazine has not declared Radhika Raje Gaikwad as the most beautiful woman of the Indian kingdom dynasty. It is a piece of fake news.Multiple social media posts circulated with a set of photographs of Radhika Raje Gaekwad, the queen of Baroda, claim that Forbes magazine has declared her the most beautiful woman of the Indian kingdom dynasty. Radhika Raje Gaikwad belongs to the royal family and is married to Maharaja Samarjit Singh Gaikwad of Vadodara in 2002. She is the Director of the CDS Art Foundation at Ahmedabad.

Her Highness Radhika Raje Gaekwad has not featured in any list announced by Forbes, nor has the magazine published any record of the most beautiful women of the Indian kingdom dynasty. There are four Indian women in a list announced by Forbes of the world's hundred most powerful women in 2019. The list featured Nirmala Sitharaman, Kiran Mazumdar-Shaw, Roshni Nadar Malhotra, and Renuka Jagtiani.

Forbes India, in its women-power edition, had announced self-made women in 2020. The list featured Ankiti Bose, Ashwiny Iyer Tiwari, and Dutee Chand. There is no truth in the information of Radhika Raje Gaekwad being declared as the most beautiful woman of the Indian dynasty.

Have a question or correction on one of our fact-checks?

If you think a claim has been misjudged or requires correction, please send us evidence to support your error claim. We will revisit our evidence and verdict and conduct additional research to verify new information.

Fact Check of the Day

misleading

397 children were diagnosed with heart inflammation after receiving Pfizer’s COVID-19 vaccine in U.S.